Investigation Discovery Orders Four-Part Andrew Tate Docuseries ‘Toxic Empire’ Set for November Premiere

Investigation Discovery has announced a new four-part documentary series titled Andrew Tate: Toxic Empire, scheduled to premiere on November 25. The cable network reported that the series will begin with a two-hour launch, followed by subsequent episodes rolling out over the following three weeks.

Series Focus and Background

The documentary examines the rise of former kickboxer and influencer Andrew Tate, alongside his younger brother, Tristan Tate. Reports indicate the series will investigate allegations concerning predatory business practices that allegedly funded their global enterprise.

According to the network, the project will cover:

• Tate's transition from kickboxing to building a webcam pornography business.
• The inner workings of the Tate brand, featuring interviews with former followers and associates.
• Characterizations of recruitment methods described by participants as cult-like tactics used to draw male followers into their orbit.
• An examination of the "War Room" international network and its "PhD" course, which former participants allege taught coercive methods for webcam recruitment.

Legal Context and Production

The announcement comes following the July arrest of Andrew Tate and Tristan Tate in Miami. Both brothers are currently fighting extradition to the UK to face multiple charges related to human trafficking and sexual assault.

Production details include:

• Directors and Producers: Julian P. Hobbs, Elli Hakami, and Adrian Murray.
• Network: Investigation Discovery (Skydance-owned).

Practical Implications and Verification

Viewers interested in verifying scheduling and broadcast details can monitor official Investigation Discovery announcements or consult television guide listings ahead of the November 25 premiere date. This project joins other previously released media about Tate, including Channel 4's *I Am Andrew Tate* and HBO Max's *Andrew Tate: Icon or Toxic? A Faking It Special*.